Literature DB >> 6477514

Comparison of apoprotein B of low density lipoproteins of human interstitial fluid and plasma.

J L Hong, J Pflug, D Reichl.   

Abstract

Virtually all apoprotein B (apoB)-containing lipoproteins of the peripheral interstitial fluid of subjects with primary lymphoedema float in the ultracentrifugal field in the density interval 1.019-1.063 g/ml; in this respect they are similar to plasma low-density lipoproteins (LDL). 2. Virtually all apo-B-containing lipoproteins of interstitial fluid migrate in the electrophoretic field with pre-beta mobility; in this respect they are similar to plasma very-low-density lipoproteins. 3. The apoB of lipoproteins of interstitial fluid does not differ in terms of Mr from apoB-100 of human plasma [Kane, Hardman & Paulus (1980) Proc. Natl. Acad. Sci. U.S.A. 77, 2465-2469] as determined by sodium dodecyl sulphate/polyacrylamide-gel electrophoresis. 4. Both apoB of interstitial fluid and plasma are heterogenous in terms of their charge as determined by isoelectric focusing of their complexes with the nonionic detergent Nonidet P40. ApoB of plasma LDL focuses between pH5.9 and 6.65, and that of interstitial fluid LDL between pH 5.9 and 6.1. Thus the overall charge of apoB of interstitial fluid is more negative than that of its plasma LDL counterpart.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6477514      PMCID: PMC1144142          DOI: 10.1042/bj2220049

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  24 in total

1.  Efficient trace-labelling of proteins with iodine.

Authors:  A S McFARLANE
Journal:  Nature       Date:  1958-07-05       Impact factor: 49.962

2.  Observations on the passage of apoproteins from plasma lipoproteins into peripheral lymph in two men.

Authors:  D Reichl; A Postiglione; N B Myant; J J Pflug; M Press
Journal:  Clin Sci Mol Med       Date:  1975-11

3.  Assay of proteins in the presence of interfering materials.

Authors:  A Bensadoun; D Weinstein
Journal:  Anal Biochem       Date:  1976-01       Impact factor: 3.365

4.  Biologically active low density lipoprotein in human peripheral lymph.

Authors:  D Reichl; N B Myant; M S Brown; J L Goldstein
Journal:  J Clin Invest       Date:  1978-01       Impact factor: 14.808

5.  On the metabolic conversion of human plasma very low density lipoprotein to low density lipoprotein.

Authors:  S Eisenberg; D W Bilheimer; R I Levy; F T Lindgren
Journal:  Biochim Biophys Acta       Date:  1973-12-20

6.  Determination of lipid phosphorus in the nanomolar range.

Authors:  A Chalvardjian; E Rudnicki
Journal:  Anal Biochem       Date:  1970-07       Impact factor: 3.365

7.  Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: recognition by receptors for acetylated low density lipoproteins.

Authors:  T Henriksen; E M Mahoney; D Steinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1981-10       Impact factor: 11.205

8.  Removal of lipids from human plasma low-density lipoprotein by detergents.

Authors:  A Helenius; K Simons
Journal:  Biochemistry       Date:  1971-06-22       Impact factor: 3.162

9.  Specificity of receptor-mediated recognition of malondialdehyde-modified low density lipoproteins.

Authors:  M E Haberland; A M Fogelman; P A Edwards
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

10.  Immunochemical heterogeneity of human plasma apolipoprotein B. I. Apolipoprotein B binding of mouse hybridoma antibodies.

Authors:  L K Curtiss; T S Edgington
Journal:  J Biol Chem       Date:  1982-12-25       Impact factor: 5.157

View more
  2 in total

Review 1.  Lymphatic transport of high-density lipoproteins and chylomicrons.

Authors:  Gwendalyn J Randolph; Norman E Miller
Journal:  J Clin Invest       Date:  2014-03-03       Impact factor: 14.808

Review 2.  Lymphatic Vessel Network Structure and Physiology.

Authors:  Jerome W Breslin; Ying Yang; Joshua P Scallan; Richard S Sweat; Shaquria P Adderley; Walter L Murfee
Journal:  Compr Physiol       Date:  2018-12-13       Impact factor: 9.090

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.